FoxO4-DRI dosage in bodybuilding is largely anecdotal. Here's what research actually shows about this senolytic peptide, plus safety and legal caveats.
There is no established FoxO4-DRI dosage for bodybuilding. FoxO4-DRI is a research-only senolytic peptide that has never been tested in human clinical trials, so every number circulating in gym forums is either extrapolated from mice or invented. Anyone injecting it is self-experimenting with a compound that is not approved for human use.
What Is FoxO4-DRI?
FoxO4-DRI (also written FOXO4-D-Retro-Inverso) is a synthetic peptide designed to block the interaction between the FOXO4 and p53 proteins. In senescent cells, that interaction keeps damaged cells alive instead of letting them die off. Blocking it in mice pushed senescent cells into apoptosis, the programmed cell death pathway.
The key study was published in Cell in 2017. Researchers gave aged mice the peptide and reported improvements in fur density, kidney function, and physical performance. That is essentially the entire evidence base: one mouse model, one research group, and no follow-up trials in people.
Interest in the foxo4 d retro inverso dri peptide has grown alongside the broader longevity and senolytics trend, which is why it now appears in bodybuilding circles next to compounds like BPC-157 and TB-500.
Why No Standard FoxO4-DRI Dosage Exists
A dosage requires human pharmacokinetic data: how fast a compound is absorbed, how long it stays active, and what blood level produces the intended effect. None of that exists for FoxO4-DRI.
- Published animal dose: roughly 5 mg/kg body weight, delivered by intraperitoneal injection in mice.
- Human data: zero clinical trials, zero published safety data, and zero established dose ranges.
- Scaling problem: mg/kg in mice does not convert directly to humans, and body-surface-area conversions usually reduce the equivalent human dose substantially.
That leaves bodybuilders copying forum numbers that were themselves copied from other forums. A frequently repeated dose is not the same thing as a studied dose.
What Bodybuilding Forums Actually Report
The table below summarizes the gap between what has been studied and what gets repeated online. Treat the anecdotal column as unverified self-reporting, not guidance.
| Source | Reported amount | Route | Evidence quality |
|---|---|---|---|
| Published mouse study (Baar et al., 2017) | Roughly 5 mg/kg | Intraperitoneal injection | Peer-reviewed animal data |
| Bodybuilding forum self-reports | 1–10 mg per week, split into 1–3 shots | Subcutaneous injection | Anecdote, unverified |
| Research chemical vendor listings | No dosing guidance; “for research use only” | Not applicable | None |
| Human clinical data | None exists | Not applicable | None |
FoxO4-DRI is not a compound you can titrate against bloodwork the way you would with testosterone. There is no lab marker that shows the dose is working, and no published range that shows it is safe.
FoxO4-DRI 10mg Vials and the Math People Use
Most suppliers sell the peptide as lyophilized powder, and foxo4-dri 10mg vials are one of the most common sizes. Users reconstitute the powder with bacteriostatic water, then draw a fraction of the vial with an insulin syringe.
A 10 mg vial mixed with 2 mL of water yields 5 mg per mL, so a “2 mg dose” equals 0.4 mL. The arithmetic is simple; the problem is that the target number itself has no scientific basis behind it. Precision in measurement does not create precision in dosing when the underlying dose was never established.
Purity is another unknown. Third-party certificates of analysis are voluntary, and independent testing has repeatedly found mislabeled or underdosed research peptides sold through online marketplaces.
Safety, Legal, and Practical Concerns
FoxO4-DRI is not FDA-approved for human use in the United States, and it is neither a dietary supplement nor a prescription drug. It is sold as a research chemical, which means it is legally intended for laboratory work only.
- Unknown long-term risk: deliberately triggering apoptosis in senescent cells could affect tissues where those cells play a protective role.
- Cancer biology caution: the p53 pathway is central to tumor suppression, and interfering with it is not a casual decision.
- Injection hazards: sterility, endotoxins, and injection-site reactions are real risks with non-pharmaceutical-grade products.
- No rescue protocol: if something goes wrong, there is no antidote and no clinical treatment pathway to follow.
Anyone considering it should speak with a physician who understands peptides and get baseline bloodwork first. A doctor cannot approve an unapproved compound, but they can at least screen for contraindications.
How FoxO4-DRI Compares With Other Gym Peptides
FoxO4-DRI sits in a different category from the peptides most bodybuilders actually use. Growth-hormone secretagogues and fat-loss fragments have at least some human dosing literature, even when they are not FDA-approved. Senolytics do not.
| Compound | Main use discussed | Commonly cited research range | FDA status |
|---|---|---|---|
| FoxO4-DRI | Senescent cell clearance | No human range established | Not approved |
| CJC-1295 without DAC | Growth hormone release | 100–200 mcg per injection | Not approved |
| AOD-9604 | Fat loss | 250–500 mcg daily | Not approved |
| PT-141 (bremelanotide) | Libido | 1.75 mg as needed | Approved for one specific indication |
| DSIP | Sleep | 100–300 mcg at night | Not approved |
| Cagrilintide | Appetite and body weight | Studied weekly in clinical trials | Not approved as a single agent |
Because those figures shift depending on the source and the indication, people often search for pt 141 dosage bodybuilding or an aod 9604 dosage protocol and end up comparing apples to oranges. If appetite-modulating compounds are the interest, cagrilintide dosage discussions pulled from clinical trials are at least grounded in human data — unlike anything published on FoxO4-DRI.
The Bottom Line on FoxO4-DRI Dosage
FoxO4-DRI is not a proven performance-enhancing peptide, and no reliable dosage for bodybuilding exists. The only published dose comes from mice, the human data is nonexistent, and the products sold online carry no guarantee of purity or sterility.
Bodybuilders chasing recovery, longevity, and better body composition have far better-documented tools: sleep, adequate protein, structured training, and physician-supervised bloodwork. If a senolytic peptide ever reaches human trials, that data will settle the dosage question. Until then, any FoxO4-DRI protocol is guesswork.
Frequently Asked Questions
What is the typical FoxO4-DRI dosage for bodybuilding?
No verified human dosage exists for FoxO4-DRI. The only published in vivo dose comes from a 2017 mouse study that used roughly 5 mg/kg by intraperitoneal injection, and mg/kg in mice does not translate directly to people. Forum-reported numbers of 1–10 mg per week are anecdotal and have no clinical data behind them.
Is FoxO4-DRI FDA-approved or legal to buy?
FoxO4-DRI is not FDA-approved for human use in the United States. It is sold as a research chemical intended for laboratory work, not as a supplement or prescription drug, so buying it for personal injection falls outside its intended labeling. Importation and possession rules can also vary by state.
Does FoxO4-DRI build muscle?
There is no evidence that FoxO4-DRI builds muscle. The mouse study measured markers of aging and tissue function, such as kidney health and fur density, rather than muscle hypertrophy or strength. No human trial has shown increases in muscle mass from this peptide.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.